世界のマイコプラズマ検査市場2020-2024

◆英語タイトル:Global Mycoplasma Testing Market 2020-2024
◆商品コード:IRTNTR43492
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年4月28日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートではマイコプラズマ検査の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別(消耗品、システム)分析、エンドユーザー別(製薬・バイオテクノロジー企業、CRO、学術研究機関、セルバンク、その他)分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・マイコプラズマ検査の世界市場:製品別(消耗品、システム)
・マイコプラズマ検査の世界市場:エンドユーザー別(製薬・バイオテクノロジー企業、CRO、学術研究機関、セルバンク、その他)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Mycoplasma Testing Market 2020-2024

Technavio has been monitoring the mycoplasma testing market and it is poised to grow by $ 445.57 million during 2020-2024 progressing at a CAGR of 11% during the forecast period. Our reports on mycoplasma testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing focus on R&D of biopharmaceuticals, increasing initiatives and funding for mycoplasma testing and rise in adoption of real-time mycoplasma testing. In addition, increasing focus on R&D of biopharmaceuticals is anticipated to boost the growth of the market as well.

The mycoplasma testing market analysis includes end-user segment and geographic landscapes
Technavio’s mycoplasma testing market is segmented as below:
By End-user
• Pharmaceutical and biotechnology companies
• Cros
• Cell banks
• Academic research institutes
• Others

By Geographic Landscapes
• North America
• Europe
• Asia
• ROW

This study identifies the growing M&A and partnerships between CROs, and pharmaceutical and biotechnology companies as one of the prime reasons driving the mycoplasma testing market growth during the next few years. Also, increasing healthcare expenditure and technological advances will lead to sizable demand in the market.
“Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our mycoplasma testing market covers the following areas:
• Mycoplasma testing market sizing
• Mycoplasma testing market forecast
• Mycoplasma testing market industry analysis”

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mycoplasma testing market vendors that include Agilent Technologies Inc., ATCC, Becton, Dickinson and Co., Charles River Laboratories International Inc., F. Hoffmann-La Roche Ltd., InvivoGen, Lonza Group Ltd., Merck KGaA, Norgen Biotek Corp., and Thermo Fisher Scientific Inc.. Also, the mycoplasma testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/global-mycoplasma-testing-market-2020-2024-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Force Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Consumables – Market size and forecast 2019-2024
o Systems – Market size and forecast 2019-2024
o Market opportunity by Product
• Market Segmentation by End-user
o Pharmaceutical and biotechnology companies
o CROs
o Academic research institutes
o Cell banks
o Others
• Customer Landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Volume driver – demand led growth
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
o Competitive scenario
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Agilent Technologies Inc.
o ATCC
o Charles River Laboratories International Inc.
o F. Hoffmann-La Roche Ltd.
o InvivoGen
o Lonza Group Ltd.
o Merck KGaA
o Norgen Biotek Corp.
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Product – Market share 2019-2024 (%)
• 22: Comparison by Product
• 23: Consumables – Market size and forecast 2019-2024 ($ million)
• 24: Consumables – Year-over-year growth 2019-2024 (%)
• 25: Systems – Market size and forecast 2019-2024 ($ million)
• 26: Systems – Year-over-year growth 2019-2024 (%)
• 27: Market opportunity by Product
• 28: Customer landscape
• 29: Market share by geography 2019-2024 (%)
• 30: Geographic comparison
• 31: North America – Market size and forecast 2019-2024 ($ million)
• 32: North America – Year-over-year growth 2019-2024 (%)
• 33: Europe – Market size and forecast 2019-2024 ($ million)
• 34: Europe – Year-over-year growth 2019-2024 (%)
• 35: Asia – Market size and forecast 2019-2024 ($ million)
• 36: Asia – Year-over-year growth 2019-2024 (%)
• 37: ROW – Market size and forecast 2019-2024 ($ million)
• 38: ROW – Year-over-year growth 2019-2024 (%)
• 39: Key leading countries
• 40: Market opportunity by geography ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: Agilent Technologies Inc. – Overview
• 48: Agilent Technologies Inc. – Business segments
• 49: Agilent Technologies Inc. – Key offerings
• 50: Agilent Technologies Inc. – Key customers
• 51: Agilent Technologies Inc. – Segment focus
• 52: ATCC – Overview
• 53: ATCC – Product and service
• 54: ATCC – Key offerings
• 55: ATCC – Key customers
• 56: ATCC – Segment focus
• 57: Becton, Dickinson and Co. – Overview
• 58: Becton, Dickinson and Co. – Business segments
• 59: Becton, Dickinson and Co. – Key offerings
• 60: Becton, Dickinson and Co. – Key customers
• 61: Becton, Dickinson and Co. – Segment focus
• 62: Charles River Laboratories International Inc. – Overview
• 63: Charles River Laboratories International Inc. – Product and service
• 64: Charles River Laboratories International Inc. – Key offerings
• 65: Charles River Laboratories International Inc. – Key customers
• 66: Charles River Laboratories International Inc. – Segment focus
• 67: F. Hoffmann-La Roche Ltd. – Overview
• 68: F. Hoffmann-La Roche Ltd. – Business segments
• 69: F. Hoffmann-La Roche Ltd. – Key offerings
• 70: F. Hoffmann-La Roche Ltd. – Key customers
• 71: F. Hoffmann-La Roche Ltd. – Segment focus
• 72: InvivoGen – Overview
• 73: InvivoGen – Business segments
• 74: InvivoGen – Key offerings
• 75: InvivoGen – Key customers
• 76: InvivoGen – Segment focus
• 77: Lonza Group Ltd. – Overview
• 78: Lonza Group Ltd. – Business segments
• 79: Lonza Group Ltd. – Key offerings
• 80: Lonza Group Ltd. – Key customers
• 81: Lonza Group Ltd. – Segment focus
• 82: Merck KGaA – Overview
• 83: Merck KGaA – Business segments
• 84: Merck KGaA – Key offerings
• 85: Merck KGaA – Key customers
• 86: Merck KGaA – Segment focus
• 87: Norgen Biotek Corp. – Overview
• 88: Norgen Biotek Corp. – Product and service
• 89: Norgen Biotek Corp. – Key offerings
• 90: Norgen Biotek Corp. – Key customers
• 91: Norgen Biotek Corp. – Segment focus
• 92: Thermo Fisher Scientific Inc. – Overview
• 93: Thermo Fisher Scientific Inc. – Business segments
• 94: Thermo Fisher Scientific Inc. – Key offerings
• 95: Thermo Fisher Scientific Inc. – Key customers
• 96: Thermo Fisher Scientific Inc. – Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations



【掲載企業】

Agilent Technologies Inc., ATCC, Becton, Dickinson and Co., Charles River Laboratories International Inc., F. Hoffmann-La Roche Ltd., InvivoGen, Lonza Group Ltd., Merck KGaA, Norgen Biotek Corp., Thermo Fisher Scientific Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のマイコプラズマ検査市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆